Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer
Clinical trial NCT06241105 · UNKNOWN
Trial details
- NCT number
- NCT06241105
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2024-12-31
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.